Appears On
Episode Appearances
Freakonomics Radio · Apr 17, 2026
671. Why Has There Been So Little Progress on Alzheimer’s Disease?
“FDA official who oversaw Aducanumab approval; left FDA to join biotech board, exemplifying regulatory capture”
Amyloid Cascade Hypothesis in Alzheimer's ResearchScientific Image Manipulation and Forensic DetectionResearch Integrity and Misconduct in Neuroscience
View Analysis